ID   KAPCG_HUMAN             Reviewed;         351 AA.
AC   P22612; O60850; Q5VZ02; Q86YI1;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   12-APR-2017, entry version 169.
DE   RecName: Full=cAMP-dependent protein kinase catalytic subunit gamma;
DE            Short=PKA C-gamma;
DE            EC=2.7.11.11;
GN   Name=PRKACG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ASP-268.
RC   TISSUE=Testis;
RX   PubMed=2342480; DOI=10.1210/mend-4-3-465;
RA   Beebe S.J., Oyen O., Sandberg M., Froysa A., Hansson V., Jahnsen T.;
RT   "Molecular cloning of a tissue-specific protein kinase (C gamma) from
RT   human testis -- representing a third isoform for the catalytic subunit
RT   of cAMP-dependent protein kinase.";
RL   Mol. Endocrinol. 4:465-475(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9598317; DOI=10.1006/geno.1998.5240;
RA   Reinton N., Haugen T.B., Orstavik S., Skalhegg B.S., Hansson V.,
RA   Jahnsen T., Tasken K.;
RT   "The gene encoding the C gamma catalytic subunit of cAMP-dependent
RT   protein kinase is a transcribed retroposon.";
RL   Genomics 49:290-297(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ASP-268.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INVOLVEMENT IN BDPLT19, VARIANT BDPLT19 MET-74, AND CHARACTERIZATION
RP   OF VARIANT BDPLT19 MET-74.
RX   PubMed=25061177; DOI=10.1182/blood-2014-01-551820;
RA   Manchev V.T., Hilpert M., Berrou E., Elaib Z., Aouba A., Boukour S.,
RA   Souquere S., Pierron G., Rameau P., Andrews R., Lanza F., Bobe R.,
RA   Vainchenker W., Rosa J.P., Bryckaert M., Debili N., Favier R.,
RA   Raslova H.;
RT   "A new form of macrothrombocytopenia induced by a germ-line mutation
RT   in the PRKACG gene.";
RL   Blood 124:2554-2563(2014).
RN   [7]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASN-251 AND ASP-268.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Phosphorylates a large number of substrates in the
CC       cytoplasm and the nucleus.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Activated by cAMP.
CC   -!- SUBUNIT: A number of inactive tetrameric holoenzymes are produced
CC       by the combination of homo- or heterodimers of the different
CC       regulatory subunits associated with two catalytic subunits. cAMP
CC       causes the dissociation of the inactive holoenzyme into a dimer of
CC       regulatory subunits bound to four cAMP and two free monomeric
CC       catalytic subunits.
CC   -!- TISSUE SPECIFICITY: Testis specific. But important tissues such as
CC       brain and ovary have not been analyzed for the content of
CC       transcript.
CC   -!- DISEASE: Bleeding disorder, platelet-type 19 (BDPLT19)
CC       [MIM:616176]: A disorder characterized by increased bleeding
CC       tendency due to platelet dysfunction. Clinical features include
CC       epistaxis, hematomas, bleeding after tooth extraction, and
CC       menorrhagia. {ECO:0000269|PubMed:25061177}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. cAMP subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC41690.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/prkacg/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M34182; AAC41690.1; ALT_INIT; mRNA.
DR   EMBL; AJ001597; CAA04863.1; -; Genomic_DNA.
DR   EMBL; DQ667175; ABG25920.1; -; Genomic_DNA.
DR   EMBL; AL162730; CAH71828.1; -; Genomic_DNA.
DR   EMBL; BC039888; AAH39888.1; -; mRNA.
DR   CCDS; CCDS6625.1; -.
DR   PIR; B34724; OKHUCG.
DR   RefSeq; NP_002723.2; NM_002732.3.
DR   UniGene; Hs.158029; -.
DR   ProteinModelPortal; P22612; -.
DR   SMR; P22612; -.
DR   BioGrid; 111555; 25.
DR   IntAct; P22612; 3.
DR   MINT; MINT-3009782; -.
DR   STRING; 9606.ENSP00000366488; -.
DR   BindingDB; P22612; -.
DR   ChEMBL; CHEMBL2743; -.
DR   GuidetoPHARMACOLOGY; 1478; -.
DR   iPTMnet; P22612; -.
DR   PhosphoSitePlus; P22612; -.
DR   BioMuta; PRKACG; -.
DR   DMDM; 33860173; -.
DR   EPD; P22612; -.
DR   MaxQB; P22612; -.
DR   PaxDb; P22612; -.
DR   PeptideAtlas; P22612; -.
DR   PRIDE; P22612; -.
DR   DNASU; 5568; -.
DR   Ensembl; ENST00000377276; ENSP00000366488; ENSG00000165059.
DR   GeneID; 5568; -.
DR   KEGG; hsa:5568; -.
DR   UCSC; uc004agy.4; human.
DR   CTD; 5568; -.
DR   DisGeNET; 5568; -.
DR   GeneCards; PRKACG; -.
DR   H-InvDB; HIX0025746; -.
DR   HGNC; HGNC:9382; PRKACG.
DR   HPA; CAB004530; -.
DR   HPA; HPA071185; -.
DR   MalaCards; PRKACG; -.
DR   MIM; 176893; gene.
DR   MIM; 616176; phenotype.
DR   neXtProt; NX_P22612; -.
DR   OpenTargets; ENSG00000165059; -.
DR   PharmGKB; PA33750; -.
DR   eggNOG; KOG0616; Eukaryota.
DR   eggNOG; ENOG410XPQQ; LUCA.
DR   GeneTree; ENSGT00810000125385; -.
DR   HOGENOM; HOG000233033; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; P22612; -.
DR   KO; K04345; -.
DR   OMA; AKKDTEQ; -.
DR   OrthoDB; EOG091G10O8; -.
DR   PhylomeDB; P22612; -.
DR   TreeFam; TF313399; -.
DR   BRENDA; 2.7.11.11; 2681.
DR   Reactome; R-HSA-111931; PKA-mediated phosphorylation of CREB.
DR   Reactome; R-HSA-163358; PKA-mediated phosphorylation of key metabolic factors.
DR   Reactome; R-HSA-163560; Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis.
DR   Reactome; R-HSA-163615; PKA activation.
DR   Reactome; R-HSA-164378; PKA activation in glucagon signalling.
DR   Reactome; R-HSA-180024; DARPP-32 events.
DR   Reactome; R-HSA-194223; HDL-mediated lipid transport.
DR   Reactome; R-HSA-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   Reactome; R-HSA-392517; Rap1 signalling.
DR   Reactome; R-HSA-422356; Regulation of insulin secretion.
DR   Reactome; R-HSA-432040; Vasopressin regulates renal water homeostasis via Aquaporins.
DR   Reactome; R-HSA-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-HSA-442720; CREB phosphorylation through the activation of Adenylate Cyclase.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5610787; Hedgehog 'off' state.
DR   Reactome; R-HSA-5621575; CD209 (DC-SIGN) signaling.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-70263; Gluconeogenesis.
DR   Reactome; R-HSA-8853659; RET signaling.
DR   Reactome; R-HSA-983231; Factors involved in megakaryocyte development and platelet production.
DR   SABIO-RK; P22612; -.
DR   SignaLink; P22612; -.
DR   SIGNOR; P22612; -.
DR   GeneWiki; PRKACG; -.
DR   GenomeRNAi; 5568; -.
DR   PRO; PR:P22612; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000165059; -.
DR   CleanEx; HS_PRKACG; -.
DR   Genevisible; P22612; HS.
DR   GO; GO:0097546; C:ciliary base; TAS:Reactome.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0045171; C:intercellular bridge; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004691; F:cAMP-dependent protein kinase activity; TAS:Reactome.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; EXP:Reactome.
DR   GO; GO:0034199; P:activation of protein kinase A activity; TAS:Reactome.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome.
DR   GO; GO:0042157; P:lipoprotein metabolic process; TAS:Reactome.
DR   GO; GO:0008584; P:male gonad development; TAS:ProtInc.
DR   GO; GO:0003091; P:renal water homeostasis; TAS:Reactome.
DR   GO; GO:0007283; P:spermatogenesis; TAS:ProtInc.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; cAMP; Complete proteome; Disease mutation; Kinase;
KW   Lipoprotein; Myristate; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    351       cAMP-dependent protein kinase catalytic
FT                                subunit gamma.
FT                                /FTId=PRO_0000086064.
FT   DOMAIN       44    298       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      299    351       AGC-kinase C-terminal.
FT   NP_BIND      50     58       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    167    167       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      73     73       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     198    198       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     339    339       Phosphoserine; by autocatalysis.
FT                                {ECO:0000250}.
FT   LIPID         2      2       N-myristoyl glycine. {ECO:0000250}.
FT   VARIANT      74     74       I -> M (in BDPLT19; patient platelets
FT                                show impaired activation;
FT                                dbSNP:rs724159972).
FT                                {ECO:0000269|PubMed:25061177}.
FT                                /FTId=VAR_072672.
FT   VARIANT     251    251       I -> N (in dbSNP:rs56287972).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040595.
FT   VARIANT     268    268       H -> D (in dbSNP:rs3730386).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:2342480,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_033902.
FT   CONFLICT    345    345       A -> P (in Ref. 5; AAH39888).
FT                                {ECO:0000305}.
SQ   SEQUENCE   351 AA;  40434 MW;  E66BB4BFB8AF9B50 CRC64;
     MGNAPAKKDT EQEESVNEFL AKARGDFLYR WGNPAQNTAS SDQFERLRTL GMGSFGRVML
     VRHQETGGHY AMKILNKQKV VKMKQVEHIL NEKRILQAID FPFLVKLQFS FKDNSYLYLV
     MEYVPGGEMF SRLQRVGRFS EPHACFYAAQ VVLAVQYLHS LDLIHRDLKP ENLLIDQQGY
     LQVTDFGFAK RVKGRTWTLC GTPEYLAPEI ILSKGYNKAV DWWALGVLIY EMAVGFPPFY
     ADQPIQIYEK IVSGRVRFPS KLSSDLKHLL RSLLQVDLTK RFGNLRNGVG DIKNHKWFAT
     TSWIAIYEKK VEAPFIPKYT GPGDASNFDD YEEEELRISI NEKCAKEFSE F
//
